药物开发药物开发

相关实验视频

Updated: Jan 7, 2026

05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Jeremy J Lin¹, Tianchen Qian¹, Bhargav Teja Nallapu²

¹University of California, Irvine, Irvine, CA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association

|December 26, 2025

概括

阿尔茨海默病 (AD) 的进展有很大的不同. 这项研究根据认知和功能变化确定了四个不同的轻度痴呆症患者群体,揭示了个性化治疗的不同疾病轨迹.

科学领域:

神经科学是一个神经科学.
老年学是指老年学的学科.
生物统计学生物统计学

背景情况:

阿尔茨海默氏病 (AD) 的进展高度异质,影响认知衰退和病理学.
了解这些不同的轨迹对于有效的治疗策略和临床试验设计至关重要.
这项研究旨在使用数据驱动的方法在轻度痴呆症中识别不同的患者群体.

研究的目的:

根据他们的认知和功能轨迹,识别轻度阿尔茨海默病 (AD) 患者的不同群体.
分析这些已识别的集群的人口和神经成像特征.
为个性化治疗策略提供信息,并改进AD的临床试验丰富设计.

主要方法:

隐性过程混合模型 (LPMM) 应用于EXPEDITION3试验安慰剂组中的924名轻度痴呆患者.
对认知 (ADAS-cog11,MMSE) 和功能 (FAQ,ADL) 标记物的纵向数据被用于集群.
集群进一步以基线人口统计和MRI衍生的大脑体积为特征.

主要成果:

确定了四个不同的AD进展集群.
集群在基线认知得分和下降速度方面存在显著差异.
磁力共振成像分析显示,各个集群的大脑体积存在差异,其中4集群体体积最大,2集群体体积最小.

结论:

纵向数据有效地将轻度阿尔茨海默病的个体分为更同质的子组.
识别的群体表现出不同的基线和进展特征,强调AD异质性.
考虑纵向模式对于个性化的AD治疗和优化临床试验设计至关重要.

相关概念视频

01:28

Preclinical Development: Overview

5.7K

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

5.7K

01:11

Clinical Trials: Overview

4.5K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

4.5K

01:26

Drug Discovery: Overview

10.9K

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

10.9K

01:26

Drug Administration and Therapy Phases: Overview

1.1K

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

1.1K

01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

279

01:25

Drug Regulation

2.7K

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...